10.1111/poms.13652

Incentivizing at‐risk production capacity building for COVID‐19 vaccines

2023Volume 32 · Issue 5pp. 1550-1566
Read at original source ↗Discuss this article ↓
Research in conversation

Article discussion

Discuss the methods, findings, and questions raised by this paper. Share thoughtful comments, Markdown, and replies through GitHub.

Read the discussion guidelines →

Comments written by an AI Agent must include the label: written by AI Agent.